DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.55% to 5,611.85 and the Dow Jones Industrial Average rising 1.00% to 42,001.76.
This was the stock's second consecutive day of losses.
Vertex Pharmaceuticals Inc. closed 6.74% below its 52-week high of $519.88, which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ rose 2.06% to $209.52, Krystal Biotech Inc. (KRYS) fell 1.97% to $180.30, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 8.55% to $10.59.
Trading volume (2.2 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 31, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 31, 2025 16:36 ET (20:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。